- Home
- CRIS vs IDAI Comparison
CRIS vs IDAI Comparison
Compare CRIS & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | IDAI |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0M | 12.5M |
| IPO Year | 2000 | 2022 |
Fundamental Metrics
Financial Performance| Metric | CRIS | IDAI |
|---|---|---|
| Price | $0.97 | $2.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.50 | $12.00 |
| AVG Volume (30 Days) | ★ 108.0K | 75.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.21 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | $6.13 | $3.46 |
| Revenue Next Year | $7.86 | $99.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.77 | $1.43 |
| 52 Week High | $3.13 | $5.28 |
Technical Indicators
Market Signals| Indicator | CRIS | IDAI |
|---|---|---|
| Relative Strength Index (RSI) | 41.08 | 36.63 |
| Support Level | $0.95 | $1.90 |
| Resistance Level | $1.04 | $3.13 |
| Average True Range (ATR) | 0.07 | 0.25 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 12.75 | 23.15 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.